Sign In
Buy OPK
$1.46
+0.0600 (+4.29%)
At Close: Jun 03, 2026
Here's Why You Should Add OPKO Health Stock to Your Portfolio
03:01pm, Thursday, 23'rd Oct 2025
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
04:05pm, Wednesday, 22'nd Oct 2025
MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U
BURLINGTON, N.C. and MIAMI , Sept.
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
01:20pm, Thursday, 11'th Sep 2025
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
Opko Health (OPK) Q2 Revenue Falls 14%
04:38pm, Friday, 01'st Aug 2025
Opko Health (OPK) Q2 Revenue Falls 14%
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
01:20pm, Friday, 01'st Aug 2025
OPKO Health reports wider-than-expected second-quarter 2025 loss and revenue decline, but gross margin expands and product sales remain stable.
OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript
09:19pm, Thursday, 31'st Jul 2025
OPKO Health, Inc. (NASDAQ:OPK ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Adam E. Logal - Senior VP & CFO Elias Adam Zerhouni - President & Vice Chairman Phillip F
Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics
08:01pm, Thursday, 31'st Jul 2025
While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare
OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates
06:46pm, Thursday, 31'st Jul 2025
OPKO Health (OPK) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.01 per share a year ago.
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results
04:05pm, Thursday, 31'st Jul 2025
MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second
NextPlat Issues Interim CEO Update Shareholder Letter
08:01am, Monday, 30'th Jun 2025
COCONUT GROVE, Fla. , June 30, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technolo
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
11:00am, Wednesday, 25'th Jun 2025
MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Mana
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
01:41pm, Friday, 13'th Jun 2025
OPK's growth hinges on RAYALDEE and key partnerships, but rising competition and reliance on one drug pose risks.
OPKO Health to Participate in Two Upcoming Investor Conferences
08:00am, Thursday, 15'th May 2025
MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in two investor conferences over the coming weeks. H.C. Wainwright 3 rd An
OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands
01:45pm, Thursday, 01'st May 2025
Despite strength in OPKO Health's revenues from the transfer of intellectual property, the company reports an overall soft first-quarter 2025 performance.
